NVAX | Novavax, Inc.

Could NVAX Have the Winning Vaccine?
Novavax announced that it would officially be entering Phase 3 of its COVID-19 vaccine candidate clinical trials in the U.K., with plans to begin in the United States by the end of October.
By Mike Sakuraba | 4 weeks ago